Ravulizumab Treatment in Pediatric Patients with Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy Is Associated with Lower Rates of Hypertension, Proteinuria Reduction, and High SurvivalMichelle Long Schoettler, Sarah Lawson, Cory T. Williams et al.|Journal of the American Society of Nephrology|2025Cited by 0
Outcomes in pediatric patients with HSCT-TMA treated with ravulizumabMichelle Long Schoettler, Franco Locatelli, Christopher C. Dvorak et al.|Blood|2025Cited by 0
Organ dysfunction in pediatric patients with HSCT-TMA treated with ravulizumabSonali Chaudhury, Franco Locatelli, David Bueno et al.|Blood|2025Cited by 0